Kelsey W. N.

Kelsey W. N. is a Principal Scientist at Cogent Biosciences as of October 2022, bringing extensive experience in CRISPR/Cas genome engineering, with a focus on gene knockout and base editing in cancer and T cells. Prior roles include Senior Scientist in Cell Biology at Horizon Discovery, where responsibilities encompassed designing and analyzing experiments to commercialize CRISPR/Cas9 base editing systems, and R&D Scientist II, emphasizing gene editing methodologies and team management. Kelsey has a solid research background from the University of Colorado Anschutz Medical Campus, where a PhD in Cancer Biology was achieved, studying resistance mechanisms in melanoma. A Bachelor of Science in Biochemistry and a Bachelor of Science in Molecular, Cellular, and Developmental Biology were obtained from the University of Colorado Boulder. Additional experience includes roles in research assistance and applied methodologies in cancer research and digital image analysis.